Pharmacoproteomics is a quickly propelling field wherein the methods of proteomics are applied to create pharmaceutical operators. The word itself was instituted uniquely in 1997.
Be that as it may, this part of study assumes a significant job in customized medication. The word proteomics itself implies the investigation of proteomes, a proteome being the full supplement of proteins communicated by a creature or tissue under indicated conditions at a predetermined time.
Proteomes are consequently powerful, and a given human may have a proteome with upwards of 2,000,000 proteins. The utilization of this full arrangement of proteins to consider the impact of illness or medications can fill in for significantly more unpredictable tests in pharmacodynamics at a lower cost in time, money related yield, and clinical hazard.
Editorial: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Commentary: Pharmacoeconomics: Open Access
Commentary: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report